EM1702H "Eosinophilic Lung Diseases" (IM GR-021017)
This presentation will focus on the role of eosinophils in a variety of lung disorders. Emphasis on the mechanisms of cytokine mediated eosinophil expansion and recruitment to the lung will be utilized to discuss newer anti-cytokine therapies being utilized in some forms of asthma. The clinical presentation and strategies for diagnosing and treating other forms of eosinophilic lung disease will be reviewed.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Discuss the role of interleukin 5 (IL-5) in expanding eosinophil number, activation state, and longevity, and to understand that this is distinct from recruitment of eosinophils to specific tissues.
- Understand the rationale for new therapies in asthma, which target IL-5, IL-4 and IL-13.
- Clinically differentiate acute and chronic eosinophilic pneumonias, and discuss drugs inducing eosinophilia.
- Review pathogens capable of causing pulmonary eosinophilia.
- Discuss the prognostic significance of eosinophilia in lung transplant patients.
Jonathan C. Weissler, M.D.
Chief of Medicine, UT Southwestern University Hospitals
James M. Collins Professor in Biomedical Research
Professor and Vice Chairman Department of Internal Medicine
Interim Director, University Hospital Hospitalist Group
- 1.00 AMA